Streetbeat News

Stock Prices

DOTUSD

Polkadot's (CRYPTO: DOT) price has seen a significant increase of 6.41% over the past 24 hours, reaching $7.64. Over the last week, the price has risen by over 12%, from $6.8. The trading volume for DOT has surged by 103% in the same period, with its circulating supply also increasing by 0.37% to 1.33 billion. Currently, Polkadot's market cap ranks it as the 14th largest, standing at $10.17 billion.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 3:03 pm

YCBD

cbdMD, Inc. (NYSE:YCBD) reported a year-over-year decrease in Q1 net sales to $5.37 million but reduced its operating loss to $1.1 million. The company launched hempMD and ATRx Labs brands, entering the hemp and functional mushroom markets. It secured financing for the national rollout of ATRx Labs products, with positive early reception. Operating expenses decreased, and direct-to-consumer sales constituted 82.3% of total net sales. The company's stock traded 4.11% lower at $0.7 per share.

Portfolio Pulse from Jelena Martinovic

February 14, 2024 | 3:03 pm

XRPUSD

XRP (CRYPTO: XRP) has seen a price increase of 3.34% in the last 24 hours, reaching $0.53, with a weekly gain of over 6.0% from $0.50. The trading volume for XRP has risen by 29.0% over the past week, and its circulating supply has increased by 0.24% to 54.51 billion, representing 54.51% of its max supply. XRP's market cap is currently ranked #6 at $29.13 billion.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 3:02 pm

AORT

Artivion (NYSE:AORT) is expected to report a quarterly EPS of $-0.10 on February 15, 2024. Investors are hopeful for a beat on this estimate and positive future guidance, which historically has had a significant impact on the stock's price. Artivion's past earnings performance shows a pattern of beating EPS estimates and experiencing subsequent stock price increases.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 3:02 pm

ATRC

AtriCure (NASDAQ:ATRC) is scheduled to release its quarterly earnings report on February 15, 2024, with an expected EPS of $-0.23. Analysts and investors are keen on whether AtriCure will surpass this estimate and provide positive guidance for the future. Historically, AtriCure has exceeded EPS estimates, leading to significant stock price increases. However, over the last year, AtriCure's shares have declined by 21.4%, indicating potential concerns among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 3:02 pm

CBZ

CBIZ (NYSE:CBZ) is scheduled to release its quarterly earnings report on February 15, 2024, with analysts expecting an EPS of $-0.28. Investors are hopeful for a beat on this estimate and positive guidance for the next quarter. CBIZ's past earnings performance shows mixed results with both beats and misses, affecting stock prices variably. Shares of CBIZ have seen a 35.98% increase over the last 52 weeks, trading at $63.35 as of February 13, indicating a generally positive sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 3:01 pm

COHU

Cohu (NASDAQ:COHU) is scheduled to release its quarterly earnings report on February 15, 2024, with an expected EPS of $0.23. Analysts and investors will be closely watching for not only an earnings beat but also positive guidance for future growth. Cohu's past earnings performance shows a mix of beats and misses, with corresponding modest stock price movements. Currently, COHU shares are trading at $32.73, reflecting a 9.37% decline over the last year, indicating investor concern ahead of the earnings announcement.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 3:01 pm

DBX

Dropbox (NASDAQ:DBX) is scheduled to release its quarterly earnings report on February 15, 2024. Analysts predict an EPS of $0.48. Historical data shows mixed reactions to past earnings, with share price movements varying post-announcement. Shares are currently trading at $32.02, up 34.47% over the last year. Investors are keen on both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 3:01 pm

DNB

Dun & Bradstreet Hldgs (NYSE:DNB) is scheduled to release its quarterly earnings report on February 15, 2024. Analysts predict an EPS of $0.31. The company's past earnings performance shows a consistent beat on EPS estimates, leading to positive stock price movements the following day. Shares are currently trading at $10.88, reflecting an 8.69% decrease over the last year. Investors are looking for positive guidance for the next quarter, which could significantly impact the stock price.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 3:01 pm

AVAXUSD

Avalanche (CRYPTO: AVAX) has seen a 6.8% increase in price over the last 24 hours, reaching $42.03, and a 21.0% increase over the past week from $34.37. The coin's all-time high is $144.96. Trading volume has surged by 120.0% in the past week, while the circulating supply decreased by 0.68%, now at 51.04% of its max supply. AVAX's market cap ranks it #10 at $15.40 billion.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 3:01 pm